Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
life sciences
national blog main
san diego blog main
san diego top stories
2
×
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
athena countouriotis
biotech ipos
boston
boston blog main
boston top stories
brett zbar
bristol-myers squibb
clinical trials
cormorant asset management
daiichi sankyo
dyne therapeutics
fda
halozyme therapeutics
hbm healthcare investments
hbm partners
jean cui
lilly asia ventures
metacrine
myotonic dystrophy type 1
national top stories
nextech invest
nonalcoholic steatohepatitis
orbimed advisors
peter li
pfizer
quizartinib
rare disease drugs
rare diseases
repotrectinib
robert adelman
salk institute
san diego
What
drug
2
×
million
raised
2
×
therapeutics
athena
biotech
brings
cancer
ceo
chief
company
countouriotis
developing
disorders
dyne
dyne’s
financing
genetic
gets
ipo
medical
medicines
mezzanine
muscle
muscular
names
new
officer
old
preclinical
promoted
push
rare
round
stage
topped
tp
upsized
year
Language
unset
Current search:
drug
×
biotech
×
raised
×
" san diego top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
